The endovenous laser therapy (EVLT) market centers on minimally invasive solutions for venous disorders, particularly varicose veins. This growing sector includes medical devices, equipment, and services that prioritize efficiency and patient comfort. EVLT's benefits, including quicker recovery and lower complication rates than conventional surgeries, contribute to its popularity. The market is characterized by a dynamic landscape influenced by evolving healthcare preferences and continuous technological advancements.
Data Bridge Market Research analyses that the Global Endovenous Laser Therapy Market, which was USD 422.16 million in 2022, is expected to reach USD 841.17 million by 2030 and is expected to undergo a CAGR of 9.0% during the forecast period 2023-2030.
"High success rate drives the market growth"
The high success rate of endovenous laser therapy (EVLT) in treating varicose veins, documented at approximately 90% vein closure in studies, underscores its efficacy. This impressive outcome translates to significant symptom relief and improved patient cosmetic appearance. The tangible and consistent positive results have played a pivotal role in the widespread adoption of EVLT, as both healthcare professionals and patients asuch as value its reliability. This success rate is a compelling driver, instilling confidence in the treatment's effectiveness and increasing acceptance within the medical community.
What restraints the growth of the global endovenous laser therapy market?
"Shortage of trained practitioners hampers the market growth"
The shortage of trained practitioners significantly impedes the growth of the endovenous laser therapy market. As demand for this minimally invasive treatment rises, insufficiently skilled professionals hamper its widespread adoption. The intricate nature of the procedure requires specialized expertise, leading to delays in patient access and limiting the market's expansion.
Segmentation: Global Endovenous Laser Therapy Market
The global endovenous laser therapy market is segmented on the basis of product type and end user.
- On the basis product type, the global endovenous laser therapy market is segmented into endovenous laser systems, and endovenous laser fibers
- On the basis of end user, the global endovenous laser therapy market is segmented into hospitals, ambulatory surgical centers, and specialized clinics
Regional Insights: North America dominates the Global Endovenous Laser Therapy Market
North America dominates the global endovenous laser therapy market due to its robust healthcare infrastructure, a significant presence of key market players, and a surge in research initiatives. The region's strong foundation in healthcare, coupled with substantial industry engagement, positions it at the forefront of advancements, contributing to the leadership of North America in the global endovenous laser therapy sector.
Asia-Pacific is expected to dominate the global endovenous laser therapy market from 2023 to 2030. This growth is attributed to increased government initiatives promoting awareness, a surge in medical tourism, expanding research activities, massive untapped markets, a large population pool, and rising demand for quality healthcare in the region. These factors position Asia-Pacific as a key player in the evolving landscape of endovenous laser therapy.
Recent Developments: Global Endovenous Laser Therapy Market
- In January 2021, Syneron Medical Ltd. introduced the Frax ProTM system, an FDA-approved and CE-marked non-ablative fractional device. Pioneering dual-depth skin resurfacing, it features both Frax 1550TM and the innovative Frax 1940TM applicators, offering advanced options for enhanced skin treatment and rejuvenation
To know more about the study, visit https://www.databridgemarketresearch.com/reports/global-endovenous-laser-therapy-market
The Prominent Key Players Operating in the Global Endovenous Laser Therapy Market Include:
- AngioDynamics (U.S.)
- Dornier MedTech GmBh (Germany)
- Alma Lasers (Israel)
- WON TECH Co., Ltd. (Korea)
- intros Medical Laser GmbH (Germany)
- biolitec AG (Germany)
- EUFOTON S.R.L (Italy)
- Teleflex Incorporated (U.S.)
- LSO Medical (France)
Above are the key players covered in the report, to know about more and exhaustive list of global endovenous laser therapy market companies, contact: https://www.databridgemarketresearch.com/contact
Research Methodology: Global Endovenous Laser Therapy Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
